Dr Antonio Gallo
Disclosure details
Participation on a Data Safety Monitoring Board or Advisory Board for Novartis, Amgen, Ultragenyx Support for attending meetings and/or travel from Amryt, Novartis Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Novartis, Amgen, Mylan Viatris, Amarin, Servier,Organon, Sanofi, Ultragenyx Consulting fees from Akcea, Sanofi Grants or contracts from any entity from Sanofi, Amgen, Amryt, UltragenyxAssociate Professor; Chief of Lipidology and Cardiovascular Prevention Unit
Sorbonne University, Pitié-Salpêtrière Hospital, 47/83 Boulevard de l’hôpital, 75013 Paris, France
Antonio Gallo, MD, PhD is Head of the Lipid Clinic and Cardiovascular Prevention Unit and Associate Professor at Sorbonne University, Pitié-Salpêtrière Hospital in Paris, France.
After completing his training in Internal Medicine at Sapienza University of Rome, Dr Gallo obtained a PhD in Physiology, Physiopathology and Therapeutics at Sorbonne University. His clinical activity focuses on the diagnostic and therapeutic management of genetic dyslipidaemias, as well as cardiovascular risk stratification of a large cohort of primary prevention subjects. His research interests include lipid metabolism, severe forms of genetic dyslipidaemias, especially familial hypercholesterolemia and familial chylomicronaemia syndrome, residual risk in primary and secondary prevention, and imaging in atherosclerosis. His current projects are focused on vascular calcifications in familial hypercholesterolemia and their role in cardiovascular risk refining and prediction, retinal microvascular remodeling in cardiometabolic disease, and Lp(a) in secondary prevention cohorts. He is principal investigator of two ongoing studies on familial hypercholesterolemia and several investigational therapeutic phase 3 trials.
He has authored or co-authored more than 50 peer-reviewed publications. He is a member of EAS (member of the Young Fellows of EAS 2019-2022), French Atherosclerosis Society NSFA (member of the scientific committee on the French registry of Familial Hypercholesterolemia), French Society of Cardiology (Member of the working group on heart and Metabolism).
